YASMEEN MEMON: Open Payments
NPI 1114098936 · LONG BRANCH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$75 in 4 payments from 3 companies in 2025. Trend: 2023 $60 · 2024 $51 · 2025 $75
Food & beverage: $75
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Alkermes, Inc. | 1 | $19 |
Products named: UZEDY, INVEGA SUSTENNA, ARISTADA.
Industry payments across NJ — which companies pay providers there.
